ストックスクリーナーアプリを入手
34.80
0.71%
-0.25
プレマーケット:
34.74
-0.06
-0.17%
前日終値:
$35.05
開ける：
$34.75
24時間の取引高:
9.44M
Relative Volume:
0.40
時価総額：
$7.92B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
50.43
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
-5.59%
1か月 パフォーマンス:
+0.26%
6か月 パフォーマンス:
-17.10%
1年 パフォーマンス:
+26.09%
1日の値動き範囲:
$34.10
$35.14
1週間の範囲:
$34.10
$37.61
52週間の値動き範囲:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
34.80 | 7.98B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
123.54 | 54.55B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.46 | 47.70B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.40B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.54 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
510.44 | 22.12B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Oluyemi Okupe Sells 23,090 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail
Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows - TradingView — Track All Markets
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
How Novo Nordisk Is Trying to Regain Its Weight-Loss Edge - Bloomberg.com
Texas Permanent School Fund Corp Invests $2.57 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
(HIMS) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Best Healthcare Stocks Worth WatchingDecember 18th - MarketBeat
Is Hims & Hers Health’s US$200 Million Ohio Bet Quietly Redefining Its Core Strategy (HIMS)? - Yahoo Finance
2 Top Stocks to Buy With $500 Right Now - Yahoo Finance
Key Financial Officer’s Major Stock Sale Raises Questions at Hims & Hers - AD HOC NEWS
Insider Sell: Michael Chi Sells 13,750 Shares of Hims & Hers Hea - GuruFocus
Michael Chi Sells 13,750 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 7,054 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Sells $367,870.91 in Stock - MarketBeat
Hims & Hers Health Insider Sold Shares Worth $308,768, According to a Recent SEC Filing - marketscreener.com
Hims & Hers Health Insider Sold Shares Worth $367,871, According to a Recent SEC Filing - marketscreener.com
Hims & Hers Health Insider Sold Shares Worth $258,952, According to a Recent SEC Filing - marketscreener.com
Hims & Hers Health Stock (HIMS) Opinions on Recent Volatility and Expansion - Quiver Quantitative
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026 - TradingView — Track All Markets
Digital health giant Hims & Hers invests $200 million to expand Ohio life sciences hub - Ohio Tech News
Telehealth company Hims & Hers investing $200 million in New Albany - The Columbus Dispatch
Hims & Hers to invest $200M in New Albany expansion, create 400 jobs - The Business Journals
COO Chi Files To Sell 13,750 Of Hims & Hers Health Inc [HIMS] - TradingView — Track All Markets
Hamilton Lane Advisors LLC Takes Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Leadership Executes Planned Stock Transactions - AD HOC NEWS
Hims & Hers Health (HIMS): Taking Stock of Valuation After a Sharp 90‑Day Pullback - Yahoo Finance
Hims & Hers Scales Technology-Driven Care as Profitability Evolves - Yahoo Finance
Healthcare Stocks To Keep An Eye OnDecember 15th - MarketBeat
Hims & Hers Health, Inc. $HIMS Holdings Raised by Nomura Holdings Inc. - MarketBeat
Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership [Video] - AOL.com
Castleark Management LLC Invests $2.92 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Marex Group plc Invests $53.63 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Q3 Earnings and Regulatory Challenges - Quiver Quantitative
Biomarker Testing Experiences - Trend Hunter
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - sharewise.com
Hims & Hers Expands Weight-Management Program to the United Kingdom - Finviz
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? - MSN
Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)
Why Novo Nordisk Stock Topped the Market on Thursday - AOL.com
Hims & Hers targets UK’s weight loss market - eMarketer
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Hims & Hers Health's Options: A Look at What the Big Money is Thinking - Benzinga
Insider Sell Alert: Perez Garcia Andrea G Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health (NYSE:HIMS) Director Garcia Andrea Perez Sells 2,500 Shares of Stock - MarketBeat
Hims stock falls after lawmakers propose GLP-1 compounding restrictions By Investing.com - Investing.com Nigeria
Hims stock falls after lawmakers propose GLP-1 compounding restrictions - Investing.com
High Short-Interest Stocks to Buy Before Q1 2026 - Investing.com
Hims & Hers launches weight-loss business in UK - pharmaphorum
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? - Finviz
Hims & Hers Health (NYSE:HIMS) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
0.36%
14.31%
大文字化:
|
ボリューム (24 時間):